skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

WED 162 Cognitive impairment in a greek ms patient cohort using bicams

Journal of neurology, neurosurgery and psychiatry, 2018-10, Vol.89 (10), p.A20-A20 [Peer Reviewed Journal]

2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2018 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0022-3050 ;EISSN: 1468-330X ;DOI: 10.1136/jnnp-2018-ABN.71

Full text available

Citations Cited by
  • Title:
    WED 162 Cognitive impairment in a greek ms patient cohort using bicams
  • Author: T, Kalatha ; E, Koutsouraki ; M, Arnaoutoglou
  • Subjects: Cognitive ability
  • Is Part Of: Journal of neurology, neurosurgery and psychiatry, 2018-10, Vol.89 (10), p.A20-A20
  • Description: IntroductionCognitive impairment (CI) can present in 40%–70% of MS patients and in the early stages of the disease. The Brief International Cognitive assessment for MS (BICAMS) is a brief, practical and potentially universal battery for cognitive assessment in MS.AimTo correlate cognitive function with clinical parameters as disease type, EDSS, and disease durationMethodsThe cognitive function was measured with the validated to the Greek population BICAMS tool, which consists of the Symbol Digit Modalities Test (SDMT), the Greek Verbal Learning Test (GVLT) and the Brief Visuospatial Memory Test-Revised (BVMT-R). Results36% patients classified as impaired according to the BICAMS battery. Progressive types of disease had worst scores than the relapsing in the SDMT (MD=1.73; 95% CI: 0.46, 3.0; p=0.009), GVLT (MD=1.77; 95% CI: 0.82, 2.72; p=0.001) and BICAMS z-score (MD=1.39; 95% CI: 0.54, 2.24; p=0.002). The two groups were also different in EDSS (p<0.001). EDSS showed correlation with BICAMS test. Disease duration did not correlate with CI. Age was identified as a risk factor of CI.DiscussionEarly management of CI can lead to improvement in the patient’s quality of life. Progressing types of the disease might benefit from early cognitive assessment in the disease course.
  • Publisher: London: BMJ Publishing Group LTD
  • Language: English
  • Identifier: ISSN: 0022-3050
    EISSN: 1468-330X
    DOI: 10.1136/jnnp-2018-ABN.71
  • Source: ProQuest One Psychology
    AUTh Library subscriptions: ProQuest Central

Searching Remote Databases, Please Wait